Related Experiment Video
Updated: Aug 18, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
Amiodarone pulmonary toxicity
1Cardiology Department of St. Luke's Episcopal Hospital and the Texas Heart Institute, Houston, Texas 77225, USA.
Abstract:
Amiodarone therapy for the treatment of arrhythmias has been found to have severe side effects. Although the drug has been prescribed in Europe for more than 20 years, it has only recently been used in the United States as an investigational drug, and has been found to cause pulmonary toxicity, as well as other major side effects. In the following report, a case of pulmonary toxicity caused by Amiodarone was resolved by steroid therapy. A review of the literature suggests that physicians prescribing this medication should be alert to the possibility of pulmonary toxicity.
Related Concept Videos
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Heart Failure Drugs: Inotropic Agents
Drug Toxicity: Risk factors
Drug Toxicity: Allergic Reactions
Pulmonary Edema II: Pathophysiology

